KDIGO Controversies Conference on the Management of Patients with Diabetes and Chronic Kidney Disease
February 5-8, 2015 Vancouver, Canada
--- CONFERENCE AGENDA ---
1
Thursday, February 5 19:00 – 21:00 hrs
19:00 hrs Welcome Reception & Informal Cocktails Location: Vistas 360
------
Friday, February 6 08:30 – 18:00 hrs
06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro
Introduction: Meeting Overview Location: Salon A
08:30 – 08:45 hrs Welcome & Introductions Presenters: John Davis, KDIGO CEO David Wheeler & Bert Kasiske, KDIGO Co-Chairs
08:45 – 09:15 hrs Conference Overview & Objectives Presenters: Per-Henrik Groop & Vlado Perkovic, Conference Co-Chairs
09:15 – 09:30 hrs Epidemiology of DKD Presenter: Per-Henrik Groop
Plenary Session #1
09:30 – 09:45 hrs What Can Be Achieved with Glycemic Control? Presenter: Michel Marre
09:45 – 10:00 hrs Balancing Risk and Benefit in Chronic Kidney Disease Presenter: Merlin Thomas
10:00 – 10:15 hrs Safety of New Agents Presenter: Steven Kahn
10:15 – 11:00 hrs Q&A
2
11:00 – 11:15 hrs Break Location: Foyer
Plenary Session #2
11:15 – 11:45 hrs Novel Treatments in DKD Presenter: Rajiv Agarwal
11:45 – 12:15 hrs Experimental Agents in DKD Presenter: Robyn Langham
12:15 – 13:00 hrs Q&A
13:00 – 14:00 hrs Lunch Location: Salon F
Plenary Session #3
14:00 – 14:15 hrs Role of Antiplatelets in DKD Presenter: Meg Jardine
14:15 – 14:30 hrs Role of Novel Anticoagulants in DKD Presenter: Vlado Perkovic
14:30 – 15:00 hrs Dyslipidemia in DKD: Current & Future Lipid-Lowering Strategies Presenter: Christoph Wanner
15:00 – 15:45 hrs Q&A
15:45 – 16:00 hrs Break Location: Foyer
Plenary Session #4
16:00 – 16:15 hrs Lifestyle & Dietary Interventions in DKD Presenter: Meg Jardine
16:15 – 16:30 hrs Is Lower the BP Target the Better in DKD? Presenter: George Bakris
3
16:30 – 16:45 hrs Is Dual Blockade in DKD Dead? Presenter: Mark Cooper
16:45 – 17:00 hrs Role of Mineralocorticoid Receptor Antagonists in DKD Presenter: Peter Rossing
17:00 – 17:45 hrs Q&A
17:45 – 18:00 hrs Closing Remarks Presenter: Vlado Perkovic
18:00 hrs Adjourn (evening on own)
------
Saturday, February 7 08:30 to 18:15 hrs
06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro
Plenary Session #5
08:30 – 08:45 hrs Improving Future Clinical Trial Designs Presenter: Dick de Zeeuw
08:45 – 09:00 hrs Moving from Efficacy to Effectiveness Presenter: Brenda Hemmelgarn
09:00 – 09:45 hrs Q&A
09:45 – 10:00 hrs Breakout Session Remit Presenters: Per-Henrik Groop & Vlado Perkovic
10:00 – 12:30 hrs Breakout Session 1 Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas Location: Salon E
4
Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn Location: Salon D
Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto Location: Salon A
Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner Location: Salon C
12:30 – 13:30 hrs Lunch Location: Salon F
Breakout Group Preliminary Reports and Discussion Location: Salon A
13:30 – 14:00 hrs Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas
14:00 – 14:30 hrs Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn
14:30 – 15:00 hrs Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto
15:00 – 15:30 hrs Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner
15:30 – 15:45 hrs Break Location: Foyer
15:45 – 18:15 hrs Breakout Session 2 Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas Location: Salon E
5
Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn Location: Salon D
Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto Location: Salon A
Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner Location: Salon C
19:00 hrs Group Dinner Location: Black & Blue Restaurant (Meet in hotel lobby at 19:00 hrs to walk to restaurant)
------
Sunday, February 8 08:30 to 12:00 hrs
06:30 – 08:30 hrs Continental Breakfast Available Location: P2B Bistro
Breakout Group Final Reports and Discussion Location: Salon A
08:30 – 09:15 hrs Breakout Group #1: Safety of Treatments in Diabetes and Kidney Disease Discussion Leaders: Brenda Hemmelgarn & Merlin Thomas
09:15 – 10:00 hrs Breakout Group #2: Efficacy of Glycemic Control Discussion Leaders: Mark Cooper & Steven Kahn
10:00 – 10:45 hrs Breakout Group #3: Therapies for Protecting Kidney Function Discussion Leaders: Rajiv Agarwal & Paola Fioretto
6
10:45 – 11:30 hrs Breakout Group #4: Therapeutic Effects on Cardiovascular Risk & Other Outcomes Discussion Leaders: Adeera Levin & Christoph Wanner
11:30 – 12:00 hrs Conference summation and next steps
7